Akoya Biosciences (United States)

Recent papers from Akoya Biosciences (United States)

1. Macrophage—Treg immunopathology in mucosal chronic graft-versus-host disease defined by single-cell and spatial profiling 2309654The Journal of Immunology · 2026
2. Spatial proteomic analysis in human Alzheimer’s disease brains enables identification of microenvironment-dependent microglial cell statesNature Neuroscience · 2026
3. Immune Checkpoint Therapy Drives Maturation of a Cellular Neighborhood Nucleated by T Cell-APC Triads Enabling Spatially Compartmentalized Tumor Immunity2026
4. MDB-14. Reshaping tumour immunity in MYC-driven medulloblastomaNeuro-Oncology Pediatrics · 2025
5. Abstract PS4-01-26: Development and Validation of TROP2/HER2-low/Ki67/HR multiplex-immunofluorescence panel with membrane identification: enabling improved Antibody Drug Conjugate therapy selectionClinical Cancer Research · 2026
6. MIF-CD74 signaling drives immune modulation in medulloblastomaNeuro-Oncology · 2026
7. Integration of imaging-based and sequencing-based spatial omics mapping on the same tissue section via DBiTplusNature Methods · 2026
8. The PROM1 + SMAD5 + Tumor-Initiating Subpopulation Shapes Premetastatic Niches through Spatial Multi-Omics Landscapes in HER2-Positive Breast Cancer癌症：英文版 · 2026
9. Anti-PD-L2 immunotherapy is efficacious against melanoma in aged hosts through IL-17 and IFNγ signallingNature Communications · 2025
10. Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell CarcinomaJournal of Clinical Oncology · 2025
11. Depleting the Action of EZH2 through PI3K–mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast CancerMolecular Cancer Therapeutics · 2025
12. Multi-omic spatial profiling reveals the unique SARS-CoV-2 lung microenvironment and collagen VI as a predictive biomarker in severe COVID-19European Respiratory Journal · 2025
13. The mutational landscape defines the proteome and spatial organization of tumor, stroma and immune cells in ovarian cancer2025
14. Spatial interaction mapping of PD-1/PD-L1 in head and neck cancer reveals the role of macrophage-tumour barriers associated with immunotherapy responseJournal of Translational Medicine · 2025
15. Assessing spatial sequencing and imaging approaches to capture the molecular and pathological heterogeneity of archived cancer tissuesThe Journal of Pathology · 2025
16. Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trialNature Communications · 2024
17. Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancerCell Reports Medicine · 2024
18. Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate CancerClinical Cancer Research · 2024
19. Abstract B063: Unveiling the immune landscape of recurrent, MYC-driven medulloblastomaCancer Research · 2024
20. Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: insights into immunotherapy responseJournal of Translational Medicine · 2024